LexDanaLexDanabeta
Inventor

XUEMING QIAN

Inventor
CN

Overview

3→
Patents
2022–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07KPeptides27%
C12NMicroorganisms or enzymes9%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
PatentTitleYear
12,162,944Human IL-4R binding antibody, antigen binding fragment thereof, and medical use thereof202411,753,473Anti-PD-L1 antibodies202311,525,005Anti-CD40 antibody, antigen binding fragment thereof and medical use thereof2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2024Patents assigned to JIANGSU HENGRUI MEDICINE CO (2)· patent assignee history
2022–2024Patents assigned to Shanghai hengrui pharmaceutical co ltd (2)· patent assignee history
2022–2024Based in CN· patent location history
2023Patents assigned to SUZHOU TRANSCENTA THERAPEUTICS CO LTD (1)· patent assignee history
2023Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
JIANGSU HENGRUI MEDICINE CO22022–2024
Shanghai hengrui pharmaceutical co ltd22022–2024
SUZHOU TRANSCENTA THERAPEUTICS CO LTD12023
Locations
LocationPatentsSpan
CN22022–2024
US12023